Table 1 Patient characteristics (N = 936)
From: Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter study
Characteristics | Value |
|---|---|
Mean age (range) | 50 (25–60) y |
FIGO stage (n, %) | |
IB1 | 6 (0.6) |
IB2 | 66 (7.1) |
IIA1 | 33 (3.5) |
IIA2 | 94 (10.0) |
IIB | 455 (48.6) |
IIIB | 243 (26.0) |
IVA | 8 (0.9) |
IVB | 31 (3.3) |
Histology (n, %) | |
Squamous cell carcinoma | 929 (99.2) |
Adenocarcinoma | 7 (0.8) |
Dose of EBRT (n, %) | |
45Gy | 96 (10.3)s |
50 Gy | 840 (89.7) |
Dose of BT (n, %) | |
24 Gy | 656 (70.1) |
30 Gy | 280 (29.9) |
Vaginal involvement (n, %) | |
Upper third | 83 (8.8%) |
No involve | 853 (91.2%) |
chemotherapy | |
Yes | 936 (100%) |
No | 0 (0) |
EBRT | |
3D-CRT | 197 (21%) |
IMRT/VMAT | 739 (79%) |
EBRT field | |
Pelvis field | 924 (98.7%) |
Extended field | 12 (1.3%) |